|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
2374240 |
| 003 |
ICU |
| 005 |
20030520211500.0 |
| 008 |
951120s1995 enka 001 0 eng d |
| 010 |
|
|
|a gb 95044785
|z 94026305
|
| 015 |
|
|
|a GB95-44785
|
| 020 |
|
|
|a 0683074040 :
|c £39.95
|
| 035 |
|
|
|a (ICU)BID21387144
|
| 035 |
|
|
|a (OCoLC)32697998
|
| 040 |
|
|
|a UKM
|c UKM
|d OrLoB-B
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 082 |
0 |
4 |
|a 615.7
|2 20
|
| 100 |
1 |
|
|a Rowland, Malcolm.
|0 http://id.loc.gov/authorities/names/n79026280
|1 http://viaf.org/viaf/41927413
|
| 245 |
1 |
0 |
|a Clinical pharmacokinetics :
|b concepts and applications /
|c Malcolm Rowland, Thomas N. Tozer.
|
| 250 |
|
|
|a 3rd ed.
|
| 260 |
|
|
|a Baltimore ;
|a London :
|b Williams & Wilkins,
|c 1995.
|
| 300 |
|
|
|a xiv, 601 p.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 500 |
|
|
|a Previous ed.: London : Lea & Febiger, 1989.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Why Clinical Pharmacokinetics? --
|g 2.
|t Basic Considerations --
|g 3.
|t Intravenous Dose --
|g 4.
|t Extravascular Dose --
|g 5.
|t Therapeutic Response and Toxicity --
|g 6.
|t Constant-Rate Regimens --
|g 7.
|t Multiple-Dose Regimens --
|g 8.
|t Movement Through Membranes --
|g 9.
|t Absorption --
|g 10.
|t Distribution --
|g 11.
|t Elimination --
|g 12.
|t Integration With Kinetics --
|g 13.
|t Variability --
|g 14.
|t Genetics --
|g 15.
|t Age and Weight --
|g 16.
|t Disease --
|g 17.
|t Interacting Drugs --
|g 18.
|t Concentration Monitoring --
|g 19.
|t Distribution Kinetics --
|g 20.
|t Pharmacologic Response --
|g 21.
|t Metabolite Kinetics --
|g 22.
|t Dose and Time Dependencies --
|g 23.
|t Turnover Concepts --
|g 24.
|t Dialysis --
|t Appendix I. Additional Concepts and Derivations --
|t Appendix II. Answers to Problems.
|
| 583 |
1 |
|
|a committed to retain
|c 20170930
|d 20421213
|f HathiTrust
|5 ICU
|
| 650 |
|
0 |
|a Pharmacokinetics.
|0 http://id.loc.gov/authorities/subjects/sh00006940
|
| 650 |
|
0 |
|a Chemotherapy.
|0 http://id.loc.gov/authorities/subjects/sh85023041
|
| 653 |
0 |
|
|a Drugs
|
| 650 |
|
7 |
|a Chemotherapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00853595
|
| 650 |
|
7 |
|a Pharmacokinetics.
|2 fast
|0 http://id.worldcat.org/fast/fst01060250
|
| 700 |
1 |
|
|a Tozer, Thomas N.
|0 http://id.loc.gov/authorities/names/n79025619
|1 http://viaf.org/viaf/66553690
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i afacd4f5-a17b-5d08-96dc-9d33c8ede257
|s 169d280d-220a-5d8d-bf4c-f2005470fb22
|
| 928 |
|
|
|t Library of Congress classification
|a RM301.5.R693 1995
|l JCL
|c JCL-Sci
|i 3422605
|
| 927 |
|
|
|t Library of Congress classification
|a RM301.5.R693 1995
|l JCL
|c JCL-Sci
|e CRERAR
|b 43504276
|i 4280416
|
